Elixir Bio-Tech Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Employees
  • 8
Employees
  • Latest Deal Type
  • Crowdfunding
  • Latest Deal Amount
  • $250K
Latest Deal Amount
  • Investors
  • 1

Elixir Bio-Tech General Information

Description

Cultivator of algae biomass for biofuel feedstock. The company cultivates algae biomass for converting feedstock to algae crude oil and developing biorefinery methodology.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Energy Production
Other Agriculture
Primary Office
  • 3109 Oak Street
  • Las Cruces, NM 88005
  • United States
+1 (575) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Elixir Bio-Tech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Equity Crowdfunding 22-Apr-2014 $250K Completed Startup
To view Elixir Bio-Tech’s complete valuation and funding history, request access »

Elixir Bio-Tech Executive Team (2)

Name Title Board Seat Contact Info
Richard Warren Co-Founder, Chief Executive Officer & President
Marie Warren Co-Founder & Senior Vice President, Manufacturing
To view Elixir Bio-Tech’s complete executive team members history, request access »

Elixir Bio-Tech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Elixir Bio-Tech Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Kevin D'Silva Angel (individual) Minority 000 0000 000000 0
To view Elixir Bio-Tech’s complete investors history, request access »